Cardiovascular disease (CVD) risk, insulin resistance and β-cell function in prehypertension population of China

Atherosclerosis

Volumn 217, Issue 1, 2011, Pages 279-285

  Chen, Gang ^a   Lai, Xiaolan ^a   Jiang, Qiqin ^a   Chen, Feng ^a   Chen, Nianhui ^a   Huang, Huibin ^a   Liang, Jixing ^a   Li, Liantao ^a   Wen, Junping ^a   Lin, Lixiang ^a   Yao, Jin ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Cell function; Cardiovascular disease (CVD) risk; Prehypertension; Type 2 diabetes

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL FUNCTION; CHINA; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECG ABNORMALITY; FEMALE; HIGH RISK POPULATION; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MATSUDA INSULIN SENSITIVITY INDEX; MICROALBUMINURIA; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PREHYPERTENSION; PRIORITY JOURNAL; RATING SCALE; SENSITIVITY ANALYSIS; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHINA; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; PREHYPERTENSION; RISK;

EID: 79960238165     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.03.030     Document Type: Article

References (51)

1. Vasan R.S., Larson M.G., Leip E.P., Kannel W.B., Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001, 358:1682-1686.
2. Gu D., Wildman R.P., Wu X., et al. Incidence and predictors of hypertension over 8 years among Chinese men and women. J Hypertens 2007, 25:517-523.
3. Winegarden C.R. From "prehypertension" to hypertension? Additional evidence. Ann Epidemiol 2005, 15:720-725.
4. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
5. Qureshi A.I., Suri M.F., Kirmani J.F., Divani A.A., Mohammad Y. Is prehypertension a risk factor for cardiovascular diseases?. Stroke 2005, 36:1859-1863.
6. De Marco M., de Simone G., Roman M.J., et al. Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study. Hypertension 2009, 54:974-980.
7. Vasan R.S., Larson M.G., Leip E.P., et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001, 345:1291-1297.
8. Bell D.S. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. N Engl J Med 2000, 343:580.
9. Mullican D.R., Lorenzo C., Haffner S.M. Is prehypertension a risk factor for the development of type 2 diabetes?. Diabetes Care 2009, 32:1870-1872.
10. Pratley R.E., Weyer C. The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia 2001, 44:929-945.
11. Kahn S.E. The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 2001, 86:4047-4058.
12. Kanauchi M., Kanauchi K., Hashimoto T., Saito Y. Metabolic syndrome and new category 'pre-hypertension' in a Japanese population. Curr Med Res Opin 2004, 20:1365-1370.
13. Sathiyapriya V., Nandeesha H., Bobby Z., Pavithran P., Selvaraj N., Rattina Dasse N. Insulin resistance and enhanced protein glycation in men with prehypertension. Clin Chem Lab Med 2006, 44:1457-1461.
14. Player M.S., Mainous A.G., Diaz V.A., Everett C.J. Prehypertension and insulin resistance in a nationally representative adult population. J Clin Hypertens (Greenwich) 2007, 9:424-429.
15. Blackburn H., Keys A., Simonson E., Rautaharju P., Punsar S. The electrocardiogram in population studies. A classification system. Circulation 1960, 21:1160-1175.
16. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
17. Bakker A.J. Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care 1999, 22:307-313.
18. WHO Obesity preventing and managing. The global epidemic-report of a WHO consultation on obesity 1997, WHO, p. 9-43.
19. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling, project. The pooling project research, group. J Chronic Dis 1978, 31:201-306.
20. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
21. Wareham N.J., Phillips D.I., Byrne C.D., Hales C.N. The 30minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion. Diabet Med 1995, 12:931.
22. Utzschneider K.M., Prigeon R.L., Faulenbach M.V., et al. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 2009, 32:335-341.
23. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
24. Greenlund K.J., Croft J.B., Mensah G.A. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med 2004, 164:2113-2118.
25. Wang Y., Wang Q.J. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med 2004, 164:2126-2134.
26. Sun Z., Zheng L., Wei Y., et al. The prevalence of prehypertension and hypertension among rural adults in Liaoning province of China. Clin Cardiol 2007, 30:183-187.
27. Li H., Xu T., Tong W., Liu Y., Zhao L., Zhang Y. Comparison of cardiovascular risk factors between prehypertension and hypertension in a Mongolian population, Inner Mongolia, China. Circ J 2008, 72:1666-1673.
28. Lee J.E., Kim Y.G., Choi Y.H., Huh W., Kim D.J., Oh H.Y. Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension 2006, 47:962-967.
29. Kim B.J., Lee H.J., Sung K.C., et al. Comparison of microalbuminuria in 2 blood pressure categories of prehypertensive subjects. Circ J 2007, 71:1283-1287.
30. Kokubo Y., Kamide K., Okamura T., et al. Impact of high-normal blood pressure on the risk of cardiovascular disease in a Japanese urban cohort: the Suita study. Hypertension 2008, 52:652-659.
31. Zhang Y., Lee E.T., Devereux R.B., et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension 2006, 47:410-414.
32. Okosun I.S., Boltri J.M., Anochie L.K., Chandra K.M. Racial/ethnic differences in prehypertension in American adults: population and relative attributable risks of abdominal obesity. J Hum Hypertens 2004, 18:849-855.
33. Cordero A., Laclaustra M., Leon M., et al. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy. Am J Hypertens 2006, 19:189-196. [discussion 197-8].
34. Pollare T., Lithell H., Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990, 39:167-174.
35. Ferrannini E., Natali A., Capaldo B., Lehtovirta M., Jacob S., Yki-Jarvinen H. Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension 1997, 30:1144-1149.
36. Hwu C.M., Liou T.L., Hsiao L.C., Lin M.W. Prehypertension is associated with insulin resistance. QJM 2009, 102:705-711.
37. Warram J.H., Martin B.C., Krolewski A.S., Soeldner J.S., Kahn C.R. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 1990, 113:909-915.
38. Jensen C.C., Cnop M., Hull R.L., Fujimoto W.Y., Kahn S.E. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes 2002, 51:2170-2178.
39. Jansson L. The regulation of pancreatic islet blood flow. Diabetes Metab Rev 1994, 10:407-416.
40. Christensen K.L., Mulvany M.J. Vasodilatation, not hypotension, improves resistance vessel design during treatment of essential hypertension: a literature survey. J Hypertens 2001, 19:1001-1006.
41. Levy B.I., Ambrosio G., Pries A.R., Struijker-Boudier H.A. Microcirculation in hypertension: a new target for treatment?. Circulation 2001, 104:735-740.
42. Iwase M., Sandler S., Carlsson P.O., Hellerstrom C., Jansson L. The pancreatic islets in spontaneously hypertensive rats: islet blood flow and insulin production. Eur J Endocrinol 2001, 144:169-178.
43. Plavnik F.L., Ajzen S.A., Christofalo D.M., Barbosa C.S., Kohlmann O. Endothelial function in normotensive and high-normal hypertensive subjects. J Hum Hypertens 2007, 21:467-472.
44. Landmesser U., Drexler H. Endothelial function and hypertension. Curr Opin Cardiol 2007, 22:316-320.
45. Tal M.G. Type 2 diabetes: microvascular ischemia of pancreatic islets?. Med Hypotheses 2009, 73:357-358.
46. Kahn S.E., Prigeon R.L., McCulloch D.K., et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993, 42:1663-1672.
47. Xiang A.H., Wang C., Peters R.K., Trigo E., Kjos S.L., Buchanan T.A. Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes. Diabetes 2006, 55:1074-1079.
48. Tabak A.G., Jokela M., Akbaraly T.N., Brunner E.J., Kivimaki M., Witte D.R. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009, 373:2215-2221.
49. Horibe H., Kasagi F., Kagaya M., Matsutani Y., Okayama A., Ueshima H. A nineteen-year cohort study on the relationship of electrocardiographic findings to all cause mortality among subjects in the national survey on circulatory disorders, NIPPON DATA80. J Epidemiol 2005, 15:125-134.
50. De Bacquer D., De Backer G., Kornitzer M., Blackburn H. Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women. Heart 1998, 80:570-577.
51. Yuyun M.F., Adler A.I., Wareham N.J. What is the evidence that microalbuminuria is a predictor of cardiovascular disease events?. Curr Opin Nephrol Hypertens 2005, 14:271-276.